Toll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation-Reference-Cited by-同舟云学术

Toll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation

Published:2022-12 Issue: Volume:634 Page:83-91
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Herik Rodrigo Acosta Gonzalez^ORCID,Tomonobu Nahoko,Yoneda Haruka,Kinoshita Rie,Mitsui Yosuke^ORCID,Sadahira Takuya,Terawaki Shin-ichi,Gohara Yuma,Gede Yoni Komalasari Ni Luh,Jiang Fan,Murata Hitoshi,Yamamoto Ken-ichi,Futami Junichiro^ORCID,Yamauchi Akira^ORCID,Kuribayashi Futoshi^ORCID,Inoue Yusuke,Kondo Eisaku,Toyooka Shinichi,Nishibori Masahiro,Watanabe Masami,Nasu Yasutomo,Sakaguchi Masakiyo^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference22 articles.

1. S100 soil sensor receptors and molecular targeting therapy against them in cancer metastasis;Tomonobu;Transl. Oncol.,2020

2. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis;Hiratsuka;Nat. Cell Biol.,2006

3. Lack of an endogenous anti-inflammatory protein in mice enhances colonization of B16F10 melanoma cells in the lungs;Saha;J. Biol. Chem.,2010

4. Bladder cancer: a review;Lenis;JAMA,2020

5. Urinary schistosomiasis and the associated bladder cancer: update;Zaghloul;J. Egypt. Natl. Cancer Inst.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATXN3 promotes proliferation, stemness and motility of clear cell renal cell carcinoma cells by regulating S100A8 ubiquitination;Physiology International;2023-12-18

2. Development of a prognostic signature for immune-associated genes in bladder cancer and exploring potential drug findings;International Urology and Nephrology;2023-09-23

3. The functions and regulatory pathways of S100A8/A9 and its receptors in cancers;Frontiers in Pharmacology;2023-08-28